why choose us

First received: June 06, 2023

Clinical Trial: Lurbinectedin in FET-Fused Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ewing Sarcoma

Study Type: INTERVENTIONAL


Official Title: Lurbinectedin in FET-Fusion Tumors (LIFFT)

Brief Summary: The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma.

Read more